PharmaShots | Incisive News in 3 Shots

Subscribe Now

Active Rheumatoid Arthritis

AbbVie's RINVOQ (upadacitinib) Receives the EC's Approval for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis

AbbVie's RINVOQ (upadacitinib) Receives the EC's Approval for the Treatment of Adults with Moderate to Severe Active Rheumatoid Ar...

December 19, 2019

AbbVie's Rinvoq (Upadacitinib) Receives CHMP Positive Opinion to Treat Moderate to Severe Active Rheumatoid Arthritis

AbbVie's Rinvoq (Upadacitinib) Receives CHMP Positive Opinion to Treat Moderate to Severe Active Rheumatoid Arthritis

October 18, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us